Professor | 方维佳 | 数字化转型顾问

	Upload Avatar (500 x 500)
Name	方维佳
Contact Information	weijiafang@zju.edu.cn
Language ability	中文, 英语
Province	浙江

Upload Avatar (500 x 500)

Name

方维佳

Contact Information

weijiafang@zju.edu.cn

Language ability

中文, 英语

Province

浙江

University/Lab Affiliation and Title	浙江大学
Faculty	Medical
Academic Background & Achievements	2008-09 至 2013-06 医学博士: 浙江大学医学院 2002-09 至 2005-06 医学硕士: 浙江大学医学院 1993-09 至 1998-06 医学学士: 浙江医科大学 2012 访问学者: 美国印第安纳大学 2011 访问学者: 香港大学
Work Experience	2019-12 至今 - 浙江大学医学院附属第一医院 - 主任医师 2008-12 至 2019-12 - 浙江大学医学院附属第一医院 - 副主任医师 2003-12 至 2008-12 - 浙江大学医学院附属第一医院 - 主治医师 1998-09 至 2003-12 - 浙江大学医学院附属第一医院 - 住院医师

University/Lab Affiliation and Title

浙江大学

Faculty

Medical

Academic Background & Achievements

2008-09 至 2013-06 医学博士: 浙江大学医学院
2002-09 至 2005-06 医学硕士: 浙江大学医学院
1993-09 至 1998-06 医学学士: 浙江医科大学
2012 访问学者: 美国印第安纳大学
2011 访问学者: 香港大学

Work Experience

2019-12 至今 - 浙江大学医学院附属第一医院 - 主任医师
2008-12 至 2019-12 - 浙江大学医学院附属第一医院 - 副主任医师
2003-12 至 2008-12 - 浙江大学医学院附属第一医院 - 主治医师
1998-09 至 2003-12 - 浙江大学医学院附属第一医院 - 住院医师

Areas of Focus	实体瘤创新细胞免疫治疗
Publications	An immunometabolism subtyping system identifies S100A9+ macrophage as an immune therapeutic target in colorectal cancer based on multiomics analysis, Bao X, Wang D, Dai X, Liu C, Zhang H, Jin Y, Tong Z, Li B, Tong C, Xin S, Li X, Wang Y, Liu L, Zhu X, Fu Q, Zheng Y, Deng J, Tian W, Guo T, Zhao P, Chen W, Fang W, 2023 Single-cell immune signature for detecting early-stage HCC and early assessing anti-PD-1 immunotherapy efficacy, Jiawei Shi, Junwei Liu, Xiaoxuan Tu, Bin Li, Zhou Tong, Tian Wang, Yi Zheng, Hongyu Shi, Xun Zeng, Wei Chen, Weiwei Yin, Weijia Fang, 2022 Emerging treatment evolutions and integrated molecular characteristics of biliary tract cancers, Ruyi Zhang, Marco Puzzoni, Stefano Mariani, Yi Zheng, Nicole Liscia, Yixuan Guo, Clelia Donisi, Yu Liu, Valentino Impera, Weijia Fang, Mario Scartozzi, 2021 Nutrition and metabolism status alteration in advanced hepatocellular carcinoma patients treated with anti-PD-1 immunotherapy, Yizhen Jiang, Xiaoxuan Tu, Xiangying Zhang, Haihong Liao, Shuwen Han, Weiqin Jiang, Yi Zheng, Peng Zhao, Zhou Tong, Qihan Fu, Quan Qi, Junjun Shen, Liping Zhong, Yuefen Pan, Weijia Fang, 2020 Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy, Xuanwen Bao, Hangyu Zhang, Wei Wu, Shaobing Cheng, Xiaomeng Dai, Xudong Zhu, Qihan Fu, Lulu Liu, Yi Zheng, Peng Zhao, Weijia Fang, Fanglong Liu, 2020 Ultra-stable biomembrane force probe for accurately determining slow dissociation kinetics of PD-1 blockade antibodies on single living cells, Chenyi An, Wei Hu, Jie Gao, Bing-Feng Ju, Peyman Obeidy, Yunduo, Charles Zhao, Xiaoxuan Tu, Weijia Fang, Lining Arnold Ju, Wei Chen, 2020 Edge Intelligence: The Confluence of Edge Computing and Artificial Intelligence, Shuiguang Deng, Hailiang Zhao, Weijia Fang, Jianwei Yin, Schahram Dustdar, Albert Y. Zomaya, 2020 Integrated analysis of single‑cell RNA‑seq and bulk RNA‑seq unravels tumour heterogeneity plus M2‑like tumour‑associated macrophage infiltration and aggressiveness in TNBC, Xuanwen Bao, Run Shi, Tianyu Zhao, Yanfang Wang, Natasa Anastasov, Michael Rosemann, Weijia Fang, 2020 Anti–PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection–Related Advanced Hepatocellular Carcinoma: A Literature Review, Bin Li, Cong Yan, Jiamin Zhu, Xiaobing Chen, Qihan Fu, Hangyu Zhang, Zhou Tong, Lulu Liu, Yi Zheng, Peng Zhao, Weiqin Jiang, Weijia Fang, 2020 Dynamic alterations of genome and transcriptome in KRAS G13D mutant CRC PDX model treated with cetuximab, Hangyu Zhang, Liyun Yuan, Lulu Liu, Cong Yan, Jinming Cheng, Qihan Fu, Zhou Tong, Weiqin Jiang, Yi Zheng, Peng Zhao, Guoqing Zhang, Weijia Fang, 2020 Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma, Yi Zheng, Tingting Wang, Xiaoxuan Tu, Yun Huang, Hangyu Zhang, Di Tan, Weiqin Jiang, Shunfeng Cai, Peng Zhao, Ruixue Song, Peilu Li, Nan Qin, Weijia Fang, 2019 Advantage of Next-Generation Sequencing in Dynamic Monitoring of Circulating Tumor DNA over Droplet Digital PCR in Cetuximab Treated Colorectal Cancer Patients, Zhang H, Liu R, Yan C, Liu L, Tong Z, Jiang W, Yao M, Fang W, Chen Z, 2018 A randomised phase II study of second-line XELIRI regimen versus irinotecan monotherapy in advanced biliary tract cancer patients progressed on gemcitabine and cisplatin, Yi Zheng, Xiaoxuan Tu, Peng Zhao, Weiqin Jiang, Lulu Liu, Zhou Tong, Hangyu Zhang, Cong Yan, Weijia Fang, Weilin Wang, 2018

Areas of Focus

实体瘤创新细胞免疫治疗

Publications

An immunometabolism subtyping system identifies S100A9+ macrophage as an immune therapeutic target in colorectal cancer based on multiomics analysis, Bao X, Wang D, Dai X, Liu C, Zhang H, Jin Y, Tong Z, Li B, Tong C, Xin S, Li X, Wang Y, Liu L, Zhu X, Fu Q, Zheng Y, Deng J, Tian W, Guo T, Zhao P, Chen W, Fang W, 2023
Single-cell immune signature for detecting early-stage HCC and early assessing anti-PD-1 immunotherapy efficacy, Jiawei Shi, Junwei Liu, Xiaoxuan Tu, Bin Li, Zhou Tong, Tian Wang, Yi Zheng, Hongyu Shi, Xun Zeng, Wei Chen, Weiwei Yin, Weijia Fang, 2022
Emerging treatment evolutions and integrated molecular characteristics of biliary tract cancers, Ruyi Zhang, Marco Puzzoni, Stefano Mariani, Yi Zheng, Nicole Liscia, Yixuan Guo, Clelia Donisi, Yu Liu, Valentino Impera, Weijia Fang, Mario Scartozzi, 2021
Nutrition and metabolism status alteration in advanced hepatocellular carcinoma patients treated with anti-PD-1 immunotherapy, Yizhen Jiang, Xiaoxuan Tu, Xiangying Zhang, Haihong Liao, Shuwen Han, Weiqin Jiang, Yi Zheng, Peng Zhao, Zhou Tong, Qihan Fu, Quan Qi, Junjun Shen, Liping Zhong, Yuefen Pan, Weijia Fang, 2020
Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy, Xuanwen Bao, Hangyu Zhang, Wei Wu, Shaobing Cheng, Xiaomeng Dai, Xudong Zhu, Qihan Fu, Lulu Liu, Yi Zheng, Peng Zhao, Weijia Fang, Fanglong Liu, 2020
Ultra-stable biomembrane force probe for accurately determining slow dissociation kinetics of PD-1 blockade antibodies on single living cells, Chenyi An, Wei Hu, Jie Gao, Bing-Feng Ju, Peyman Obeidy, Yunduo, Charles Zhao, Xiaoxuan Tu, Weijia Fang, Lining Arnold Ju, Wei Chen, 2020
Edge Intelligence: The Confluence of Edge Computing and Artificial Intelligence, Shuiguang Deng, Hailiang Zhao, Weijia Fang, Jianwei Yin, Schahram Dustdar, Albert Y. Zomaya, 2020
Integrated analysis of single‑cell RNA‑seq and bulk RNA‑seq unravels tumour heterogeneity plus M2‑like tumour‑associated macrophage infiltration and aggressiveness in TNBC, Xuanwen Bao, Run Shi, Tianyu Zhao, Yanfang Wang, Natasa Anastasov, Michael Rosemann, Weijia Fang, 2020
Anti–PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection–Related Advanced Hepatocellular Carcinoma: A Literature Review, Bin Li, Cong Yan, Jiamin Zhu, Xiaobing Chen, Qihan Fu, Hangyu Zhang, Zhou Tong, Lulu Liu, Yi Zheng, Peng Zhao, Weiqin Jiang, Weijia Fang, 2020
Dynamic alterations of genome and transcriptome in KRAS G13D mutant CRC PDX model treated with cetuximab, Hangyu Zhang, Liyun Yuan, Lulu Liu, Cong Yan, Jinming Cheng, Qihan Fu, Zhou Tong, Weiqin Jiang, Yi Zheng, Peng Zhao, Guoqing Zhang, Weijia Fang, 2020
Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma, Yi Zheng, Tingting Wang, Xiaoxuan Tu, Yun Huang, Hangyu Zhang, Di Tan, Weiqin Jiang, Shunfeng Cai, Peng Zhao, Ruixue Song, Peilu Li, Nan Qin, Weijia Fang, 2019
Advantage of Next-Generation Sequencing in Dynamic Monitoring of Circulating Tumor DNA over Droplet Digital PCR in Cetuximab Treated Colorectal Cancer Patients, Zhang H, Liu R, Yan C, Liu L, Tong Z, Jiang W, Yao M, Fang W, Chen Z, 2018
A randomised phase II study of second-line XELIRI regimen versus irinotecan monotherapy in advanced biliary tract cancer patients progressed on gemcitabine and cisplatin, Yi Zheng, Xiaoxuan Tu, Peng Zhao, Weiqin Jiang, Lulu Liu, Zhou Tong, Hangyu Zhang, Cong Yan, Weijia Fang, Weilin Wang, 2018

细胞免疫治疗实体瘤临床研究 Car-T治疗 Nk细胞癌症治疗免疫治疗肿瘤学临床试验创新疗法

王青青 - 浙江大学

任俊明 - 浙江大学

潘荣清 - 浙江大学

View All

Personal Information

Academic Information

Research

联系我们

还未创建账户?

Personal Information

Academic Information

Research

联系我们